Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Builds a model to study primary Sjogren's syndrome using combined treatments

Collects molecular data from adults with Sjogren's syndrome to build diagnosis and prognosis models.

Plain-language title generated from the registry record
Registry title: Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine

Key facts

Where
Beijing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT06528197, who can take part

Where in China

  • Jiaqi ChenBeijing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
China-Japan Friendship Hospital
Trial code
NCT06528197
Record updated
30 July 2024
Original description
This study aims to establish a large sample cohort of patients with primary sjogren's syndrome, collect multi-omics information of patients with primary sjogren's syndrome, and construct disease diagnosis model and disease prognosis prediction model.Read full original descriptionShow less

Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese Medicine and Western Medicine Based on Multi-omics

This study aims to establish a large sample cohort of patients with primary sjogren's syndrome, collect multi-omics information of patients with primary sjogren's syndrome, and construct disease diagnosis model and disease prognosis prediction model.

Inclusion: Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren's syndrome.

Exclusion: Comorbid connective tissue disease other than the disease under research; Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure, or severe malignant tumors; Other conditions (e.g., cognitive impairment) that the investigators consider ineligible for enrollment; Women who are pregnant or breastfeeding.

ClinicalTrials.gov NCT06528197